Search

everythinglearnresearchcommunity

for

Search:↓

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

The document concludes that better understanding the wound microbiome can improve chronic wound care by preserving helpful bacteria and targeting harmful ones.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Iron deficiency might contribute to hair loss in women.

A patient grew extra hair on their ears after treatment for testicular cancer, possibly due to hormonal changes or genetics.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Tamsulosin works faster, but both drugs have similar effects after 6 months.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

A group has developed therapies that show promise for treating cancer and various other conditions.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Higher IL-17A levels indicate more severe alopecia areata.